Articles from GEVORKYAN, a.s.
"Using our DCF model and a calculated WACC of 6,9 %, we determine a fair value of CZK 300 and a 12-month price target of CZK 321," notes Dr. Kalliwoda Research GmbH in analytical report GEVORKYAN, a.s. Initiation of Coverage H1 2025, dated November 10, 2025.
By GEVORKYAN, a.s. · Via GlobeNewswire · November 11, 2025
"Applying standard valuation multiples to the annualized H1 2025 results, the fair value of the share is estimated to range between 310 CZK and 330 CZK, indicating that the current market price does not fully reflect the company’s intrinsic value," according to Gafrik Research.
By GEVORKYAN, a.s. · Via GlobeNewswire · November 4, 2025
By GEVORKYAN, a.s. · Via GlobeNewswire · October 28, 2025
Press Release
By GEVORKYAN, a.s. · Via GlobeNewswire · October 17, 2025
Prague, 17 September 2025
By GEVORKYAN, a.s. · Via GlobeNewswire · September 17, 2025
By GEVORKYAN, a.s. · Via GlobeNewswire · August 20, 2025
The share buyback programme for employees was approved at the Annual General Meeting held on December 10, 2024.
By GEVORKYAN, a.s. · Via GlobeNewswire · June 26, 2025
Readiness for further growth
By GEVORKYAN, a.s. · Via GlobeNewswire · June 23, 2025

Press Release
By GEVORKYAN, a.s. · Via GlobeNewswire · June 3, 2025
Press Release: Q1 2025 Trading update
By GEVORKYAN, a.s. · Via GlobeNewswire · May 16, 2025